At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled
Drug / intervention
STAMP+CBT applicationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Harnessing Mobile Technology to Deliver Tailored, Brief Pain-CBT for Advanced Cancer Patients on Opioids for Pain
In Brief
A clinical study evaluating STAMP+CBT application for Active Cancer and 4 related conditions. Completed, enrolled 10 participants across 3 sites.
Detailed Summary
The purpose of this study is to test whether a mobile application developed to help people with cancer pain is useful and helpful to patients with cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsActive Cancer, Active Cancer Treatment, Advanced Cancer, Palliative Care, Chronic Pain Due to Cancer
CountriesUnited States
CollaboratorsNational Palliative Care Research Center
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartJul 2022
Primary CompletionJun 2023
Study CompletionJun 2023
TodayJul 2026
First PostedJun 3, 2022
Enrollment StartJul 1, 2022
Primary CompletionJun 8, 2023
Study CompletionJun 27, 2023
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.1 years ago
Interventions
STAMP+CBT applicationbehavioral
Use the STAMP+CBT mobile app for 4 weeks (intervention period, 4 weeks for content introduction, extended 2 weeks for review of content if patient's request this